Trial record 1 of 3 for:    NCT00120289
Previous Study | Return to List | Next Study

Niacin Plus Statin to Prevent Vascular Events

This study has been terminated.
(AIM-HIGH was stopped on the recommendation of the DSMB because of lack of efficacy of niacin in preventing primary outcome events.)
Information provided by (Responsible Party):
Ruth McBride, Axio Research. LLC Identifier:
First received: July 6, 2005
Last updated: January 9, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2012
  Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):